The role involves overseeing nonclinical safety evaluation programs for selected drug candidates across oncology, hematology, and other therapeutic areas.
Base: $178,690 - $249,003 depending on location; Bonus/Equity: Additional incentive cash and stock opportunities available; Benefits: Comprehensive medical, dental, vision, 401(k), and paid time off included
Must-have
Nice-to-have
Not specified